We are pleased to announce that Prof. Dr. Felipe Fregni has been appointed Editor-in-Chief of Biomedicines (ISSN: 2227-9059).

Name: Prof. Dr. Felipe Fregni

Homepage: https://www.hsph.harvard.edu/ecpe/faculty/felipe-fregni/

Affiliation: ^1.Neuromodulation Center and Center for Clinical Research Learning, Spaulding Rehabilitation Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; ^2.Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA

Interests: neuromodulation; pain perception modulation; neurophysiology; neuroplasticity

Prof. Dr. Fregni is a Professor of epidemiology at Harvard T.H. Chan School of Public Health and PM&R at Harvard Medical School. He leads a large clinical research laboratory (Spaulding Neuromodulation Center) funded by major NIH grants and is currently investigating techniques to guide and measure neuroplasticity in brain injury. He has been at the forefront of advancing neurorehabilitation science to treat conditions such as stroke, Parkinson’s disease, and chronic pain. He holds an M.D. and Ph.D. from the University of Sao Paulo, Brazil, and three master’s degrees from Harvard University. He has more than 580 peer-reviewed publications and has been leading the international training program Principles. In recognition of his outstanding contributions, he has been awarded the highest honor bestowed by the United States government to outstanding scientists and engineers in the U.S.: the Presidential Early Career Award for Scientists and Engineers (PECASE).

Currently, his research focuses on understanding neuroplastic changes associated with conditions such as chronic pain, Parkinson’s disease, and stroke, using non-invasive brain stimulation as an investigative tool for such aims.

We warmly welcome our new Editor-in-Chief and wish the journal every success in the future.